Time interval between the completion of radiotherapy and robotic-assisted surgery among patients with stage I–III rectal cancer undergoing preoperative chemoradiotherapy

This aim of this study was to evaluate the effects of time interval between the completion of radiotherapy and robotic-assisted surgery on the outcomes among patients with rectal cancer undergoing preoperative concurrent chemoradiotherapy (CCRT). In total, 116 patients with stage I-III rectal cancer...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 15; no. 10; p. e0240742
Main Authors Huang, Ching-Wen, Su, Wei-Chih, Yin, Tzu-Chieh, Chen, Po-Jung, Chang, Tsung-Kun, Chen, Yen-Cheng, Li, Ching-Chun, Hsieh, Yi-Chien, Tsai, Hsiang-Lin, Wang, Jaw-Yuan
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 16.10.2020
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This aim of this study was to evaluate the effects of time interval between the completion of radiotherapy and robotic-assisted surgery on the outcomes among patients with rectal cancer undergoing preoperative concurrent chemoradiotherapy (CCRT). In total, 116 patients with stage I-III rectal cancer who underwent preoperative CCRT and robotic-assisted surgery between September 2013 and February 2019 were enrolled. Patients were categorized into two groups based on the time interval: group A (10-12 weeks) and group B (≥ 12 weeks). Among the 116 enrolled patients, 98 (84.5%) had middle and lower rectal cancers. Two (1.7%) patients underwent abdominoperineal resection with a sphincter preservation rate of 98.3%. Thirty-seven (31.9%) patients had a pathologic complete response (pCR). The circumferential resection margin and distal resection margin were positive in 2 (1.7%) and 1 (0.9%) patients, respectively. Therefore, the R0 resection rate was 97.4%. A total of 24 (22.4%) patients experienced postoperative relapse and 12 (10.3%) patients died; these were slightly more common in group B than in group A (28.8% vs 15.8% and 15.3% vs 5.3%, respectively; both P > 0.05); however, this difference was nonsignificant. Three-year disease-free survival (DFS) and overall survival (OS) were 75% and 89%, respectively, among all patients. Non-significant trend of favorable 3-year DFS, 3-year OS, 3-year locoregional control rate and 3-year distant metastasis control rate were observed in group A compared with group B (all P > 0.05). Robotic-assisted surgery after a longer interval is safe and feasible for patients with rectal cancer undergoing preoperative CCRT. The present study's results suggested that the time interval of 10-12 weeks can be considered because comparable clinical and perioperative outcomes and preferable oncological outcomes were observed for interval of this length. However, future prospective randomized clinical trials are required to verify the present finding.
AbstractList This aim of this study was to evaluate the effects of time interval between the completion of radiotherapy and robotic-assisted surgery on the outcomes among patients with rectal cancer undergoing preoperative concurrent chemoradiotherapy (CCRT). In total, 116 patients with stage I-III rectal cancer who underwent preoperative CCRT and robotic-assisted surgery between September 2013 and February 2019 were enrolled. Patients were categorized into two groups based on the time interval: group A (10-12 weeks) and group B (≥ 12 weeks). Among the 116 enrolled patients, 98 (84.5%) had middle and lower rectal cancers. Two (1.7%) patients underwent abdominoperineal resection with a sphincter preservation rate of 98.3%. Thirty-seven (31.9%) patients had a pathologic complete response (pCR). The circumferential resection margin and distal resection margin were positive in 2 (1.7%) and 1 (0.9%) patients, respectively. Therefore, the R0 resection rate was 97.4%. A total of 24 (22.4%) patients experienced postoperative relapse and 12 (10.3%) patients died; these were slightly more common in group B than in group A (28.8% vs 15.8% and 15.3% vs 5.3%, respectively; both P > 0.05); however, this difference was nonsignificant. Three-year disease-free survival (DFS) and overall survival (OS) were 75% and 89%, respectively, among all patients. Non-significant trend of favorable 3-year DFS, 3-year OS, 3-year locoregional control rate and 3-year distant metastasis control rate were observed in group A compared with group B (all P > 0.05). Robotic-assisted surgery after a longer interval is safe and feasible for patients with rectal cancer undergoing preoperative CCRT. The present study's results suggested that the time interval of 10-12 weeks can be considered because comparable clinical and perioperative outcomes and preferable oncological outcomes were observed for interval of this length. However, future prospective randomized clinical trials are required to verify the present finding.
Background This aim of this study was to evaluate the effects of time interval between the completion of radiotherapy and robotic-assisted surgery on the outcomes among patients with rectal cancer undergoing preoperative concurrent chemoradiotherapy (CCRT). Methods In total, 116 patients with stage I–III rectal cancer who underwent preoperative CCRT and robotic-assisted surgery between September 2013 and February 2019 were enrolled. Patients were categorized into two groups based on the time interval: group A (10–12 weeks) and group B (≥ 12 weeks). Results Among the 116 enrolled patients, 98 (84.5%) had middle and lower rectal cancers. Two (1.7%) patients underwent abdominoperineal resection with a sphincter preservation rate of 98.3%. Thirty-seven (31.9%) patients had a pathologic complete response (pCR). The circumferential resection margin and distal resection margin were positive in 2 (1.7%) and 1 (0.9%) patients, respectively. Therefore, the R0 resection rate was 97.4%. A total of 24 (22.4%) patients experienced postoperative relapse and 12 (10.3%) patients died; these were slightly more common in group B than in group A (28.8% vs 15.8% and 15.3% vs 5.3%, respectively; both P > 0.05); however, this difference was nonsignificant. Three-year disease-free survival (DFS) and overall survival (OS) were 75% and 89%, respectively, among all patients. Non-significant trend of favorable 3-year DFS, 3-year OS, 3-year locoregional control rate and 3-year distant metastasis control rate were observed in group A compared with group B (all P > 0.05). Conclusion Robotic-assisted surgery after a longer interval is safe and feasible for patients with rectal cancer undergoing preoperative CCRT. The present study’s results suggested that the time interval of 10–12 weeks can be considered because comparable clinical and perioperative outcomes and preferable oncological outcomes were observed for interval of this length. However, future prospective randomized clinical trials are required to verify the present finding.
Background This aim of this study was to evaluate the effects of time interval between the completion of radiotherapy and robotic-assisted surgery on the outcomes among patients with rectal cancer undergoing preoperative concurrent chemoradiotherapy (CCRT). Methods In total, 116 patients with stage I-III rectal cancer who underwent preoperative CCRT and robotic-assisted surgery between September 2013 and February 2019 were enrolled. Patients were categorized into two groups based on the time interval: group A (10-12 weeks) and group B ([greater than or equal to] 12 weeks). Results Among the 116 enrolled patients, 98 (84.5%) had middle and lower rectal cancers. Two (1.7%) patients underwent abdominoperineal resection with a sphincter preservation rate of 98.3%. Thirty-seven (31.9%) patients had a pathologic complete response (pCR). The circumferential resection margin and distal resection margin were positive in 2 (1.7%) and 1 (0.9%) patients, respectively. Therefore, the R0 resection rate was 97.4%. A total of 24 (22.4%) patients experienced postoperative relapse and 12 (10.3%) patients died; these were slightly more common in group B than in group A (28.8% vs 15.8% and 15.3% vs 5.3%, respectively; both P > 0.05); however, this difference was nonsignificant. Three-year disease-free survival (DFS) and overall survival (OS) were 75% and 89%, respectively, among all patients. Non-significant trend of favorable 3-year DFS, 3-year OS, 3-year locoregional control rate and 3-year distant metastasis control rate were observed in group A compared with group B (all P > 0.05). Conclusion Robotic-assisted surgery after a longer interval is safe and feasible for patients with rectal cancer undergoing preoperative CCRT. The present study's results suggested that the time interval of 10-12 weeks can be considered because comparable clinical and perioperative outcomes and preferable oncological outcomes were observed for interval of this length. However, future prospective randomized clinical trials are required to verify the present finding.
Background This aim of this study was to evaluate the effects of time interval between the completion of radiotherapy and robotic-assisted surgery on the outcomes among patients with rectal cancer undergoing preoperative concurrent chemoradiotherapy (CCRT). Methods In total, 116 patients with stage I–III rectal cancer who underwent preoperative CCRT and robotic-assisted surgery between September 2013 and February 2019 were enrolled. Patients were categorized into two groups based on the time interval: group A (10–12 weeks) and group B (≥ 12 weeks). Results Among the 116 enrolled patients, 98 (84.5%) had middle and lower rectal cancers. Two (1.7%) patients underwent abdominoperineal resection with a sphincter preservation rate of 98.3%. Thirty-seven (31.9%) patients had a pathologic complete response (pCR). The circumferential resection margin and distal resection margin were positive in 2 (1.7%) and 1 (0.9%) patients, respectively. Therefore, the R0 resection rate was 97.4%. A total of 24 (22.4%) patients experienced postoperative relapse and 12 (10.3%) patients died; these were slightly more common in group B than in group A (28.8% vs 15.8% and 15.3% vs 5.3%, respectively; both P > 0.05); however, this difference was nonsignificant. Three-year disease-free survival (DFS) and overall survival (OS) were 75% and 89%, respectively, among all patients. Non-significant trend of favorable 3-year DFS, 3-year OS, 3-year locoregional control rate and 3-year distant metastasis control rate were observed in group A compared with group B (all P > 0.05). Conclusion Robotic-assisted surgery after a longer interval is safe and feasible for patients with rectal cancer undergoing preoperative CCRT. The present study’s results suggested that the time interval of 10–12 weeks can be considered because comparable clinical and perioperative outcomes and preferable oncological outcomes were observed for interval of this length. However, future prospective randomized clinical trials are required to verify the present finding.
This aim of this study was to evaluate the effects of time interval between the completion of radiotherapy and robotic-assisted surgery on the outcomes among patients with rectal cancer undergoing preoperative concurrent chemoradiotherapy (CCRT). In total, 116 patients with stage I-III rectal cancer who underwent preoperative CCRT and robotic-assisted surgery between September 2013 and February 2019 were enrolled. Patients were categorized into two groups based on the time interval: group A (10-12 weeks) and group B ([greater than or equal to] 12 weeks). Among the 116 enrolled patients, 98 (84.5%) had middle and lower rectal cancers. Two (1.7%) patients underwent abdominoperineal resection with a sphincter preservation rate of 98.3%. Thirty-seven (31.9%) patients had a pathologic complete response (pCR). The circumferential resection margin and distal resection margin were positive in 2 (1.7%) and 1 (0.9%) patients, respectively. Therefore, the R0 resection rate was 97.4%. A total of 24 (22.4%) patients experienced postoperative relapse and 12 (10.3%) patients died; these were slightly more common in group B than in group A (28.8% vs 15.8% and 15.3% vs 5.3%, respectively; both P > 0.05); however, this difference was nonsignificant. Three-year disease-free survival (DFS) and overall survival (OS) were 75% and 89%, respectively, among all patients. Non-significant trend of favorable 3-year DFS, 3-year OS, 3-year locoregional control rate and 3-year distant metastasis control rate were observed in group A compared with group B (all P > 0.05). Robotic-assisted surgery after a longer interval is safe and feasible for patients with rectal cancer undergoing preoperative CCRT. The present study's results suggested that the time interval of 10-12 weeks can be considered because comparable clinical and perioperative outcomes and preferable oncological outcomes were observed for interval of this length. However, future prospective randomized clinical trials are required to verify the present finding.
BackgroundThis aim of this study was to evaluate the effects of time interval between the completion of radiotherapy and robotic-assisted surgery on the outcomes among patients with rectal cancer undergoing preoperative concurrent chemoradiotherapy (CCRT).MethodsIn total, 116 patients with stage I-III rectal cancer who underwent preoperative CCRT and robotic-assisted surgery between September 2013 and February 2019 were enrolled. Patients were categorized into two groups based on the time interval: group A (10-12 weeks) and group B (≥ 12 weeks).ResultsAmong the 116 enrolled patients, 98 (84.5%) had middle and lower rectal cancers. Two (1.7%) patients underwent abdominoperineal resection with a sphincter preservation rate of 98.3%. Thirty-seven (31.9%) patients had a pathologic complete response (pCR). The circumferential resection margin and distal resection margin were positive in 2 (1.7%) and 1 (0.9%) patients, respectively. Therefore, the R0 resection rate was 97.4%. A total of 24 (22.4%) patients experienced postoperative relapse and 12 (10.3%) patients died; these were slightly more common in group B than in group A (28.8% vs 15.8% and 15.3% vs 5.3%, respectively; both P > 0.05); however, this difference was nonsignificant. Three-year disease-free survival (DFS) and overall survival (OS) were 75% and 89%, respectively, among all patients. Non-significant trend of favorable 3-year DFS, 3-year OS, 3-year locoregional control rate and 3-year distant metastasis control rate were observed in group A compared with group B (all P > 0.05).ConclusionRobotic-assisted surgery after a longer interval is safe and feasible for patients with rectal cancer undergoing preoperative CCRT. The present study's results suggested that the time interval of 10-12 weeks can be considered because comparable clinical and perioperative outcomes and preferable oncological outcomes were observed for interval of this length. However, future prospective randomized clinical trials are required to verify the present finding.
This aim of this study was to evaluate the effects of time interval between the completion of radiotherapy and robotic-assisted surgery on the outcomes among patients with rectal cancer undergoing preoperative concurrent chemoradiotherapy (CCRT).BACKGROUNDThis aim of this study was to evaluate the effects of time interval between the completion of radiotherapy and robotic-assisted surgery on the outcomes among patients with rectal cancer undergoing preoperative concurrent chemoradiotherapy (CCRT).In total, 116 patients with stage I-III rectal cancer who underwent preoperative CCRT and robotic-assisted surgery between September 2013 and February 2019 were enrolled. Patients were categorized into two groups based on the time interval: group A (10-12 weeks) and group B (≥ 12 weeks).METHODSIn total, 116 patients with stage I-III rectal cancer who underwent preoperative CCRT and robotic-assisted surgery between September 2013 and February 2019 were enrolled. Patients were categorized into two groups based on the time interval: group A (10-12 weeks) and group B (≥ 12 weeks).Among the 116 enrolled patients, 98 (84.5%) had middle and lower rectal cancers. Two (1.7%) patients underwent abdominoperineal resection with a sphincter preservation rate of 98.3%. Thirty-seven (31.9%) patients had a pathologic complete response (pCR). The circumferential resection margin and distal resection margin were positive in 2 (1.7%) and 1 (0.9%) patients, respectively. Therefore, the R0 resection rate was 97.4%. A total of 24 (22.4%) patients experienced postoperative relapse and 12 (10.3%) patients died; these were slightly more common in group B than in group A (28.8% vs 15.8% and 15.3% vs 5.3%, respectively; both P > 0.05); however, this difference was nonsignificant. Three-year disease-free survival (DFS) and overall survival (OS) were 75% and 89%, respectively, among all patients. Non-significant trend of favorable 3-year DFS, 3-year OS, 3-year locoregional control rate and 3-year distant metastasis control rate were observed in group A compared with group B (all P > 0.05).RESULTSAmong the 116 enrolled patients, 98 (84.5%) had middle and lower rectal cancers. Two (1.7%) patients underwent abdominoperineal resection with a sphincter preservation rate of 98.3%. Thirty-seven (31.9%) patients had a pathologic complete response (pCR). The circumferential resection margin and distal resection margin were positive in 2 (1.7%) and 1 (0.9%) patients, respectively. Therefore, the R0 resection rate was 97.4%. A total of 24 (22.4%) patients experienced postoperative relapse and 12 (10.3%) patients died; these were slightly more common in group B than in group A (28.8% vs 15.8% and 15.3% vs 5.3%, respectively; both P > 0.05); however, this difference was nonsignificant. Three-year disease-free survival (DFS) and overall survival (OS) were 75% and 89%, respectively, among all patients. Non-significant trend of favorable 3-year DFS, 3-year OS, 3-year locoregional control rate and 3-year distant metastasis control rate were observed in group A compared with group B (all P > 0.05).Robotic-assisted surgery after a longer interval is safe and feasible for patients with rectal cancer undergoing preoperative CCRT. The present study's results suggested that the time interval of 10-12 weeks can be considered because comparable clinical and perioperative outcomes and preferable oncological outcomes were observed for interval of this length. However, future prospective randomized clinical trials are required to verify the present finding.CONCLUSIONRobotic-assisted surgery after a longer interval is safe and feasible for patients with rectal cancer undergoing preoperative CCRT. The present study's results suggested that the time interval of 10-12 weeks can be considered because comparable clinical and perioperative outcomes and preferable oncological outcomes were observed for interval of this length. However, future prospective randomized clinical trials are required to verify the present finding.
Audience Academic
Author Chen, Po-Jung
Su, Wei-Chih
Yin, Tzu-Chieh
Hsieh, Yi-Chien
Chang, Tsung-Kun
Tsai, Hsiang-Lin
Huang, Ching-Wen
Wang, Jaw-Yuan
Chen, Yen-Cheng
Li, Ching-Chun
AuthorAffiliation 1 Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
4 Department of Surgery, Kaohsiung Municipal Tatung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
6 Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
9 Clinical Pharmacogenomics and Pharmacoproteomics, School of Pharmacy, Taipei Medical University, Taipei, Taiwan
7 Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
5 Division of Colorectal Surgery, Department of Surgery, Kaohsiung Municipal Hsiaokang Hospital, Kaohsiung, Taiwan
Chang Gung Memorial Hospital at Linkou, TAIWAN
3 Division of General and Digestive Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
2 Department of Surgery, Faculty of Medicine, College of Medicine, Kaohsiung Medical University Hospital, Ka
AuthorAffiliation_xml – name: 3 Division of General and Digestive Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
– name: Chang Gung Memorial Hospital at Linkou, TAIWAN
– name: 2 Department of Surgery, Faculty of Medicine, College of Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
– name: 7 Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
– name: 4 Department of Surgery, Kaohsiung Municipal Tatung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
– name: 6 Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
– name: 8 Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan
– name: 5 Division of Colorectal Surgery, Department of Surgery, Kaohsiung Municipal Hsiaokang Hospital, Kaohsiung, Taiwan
– name: 9 Clinical Pharmacogenomics and Pharmacoproteomics, School of Pharmacy, Taipei Medical University, Taipei, Taiwan
– name: 1 Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
Author_xml – sequence: 1
  givenname: Ching-Wen
  surname: Huang
  fullname: Huang, Ching-Wen
– sequence: 2
  givenname: Wei-Chih
  surname: Su
  fullname: Su, Wei-Chih
– sequence: 3
  givenname: Tzu-Chieh
  surname: Yin
  fullname: Yin, Tzu-Chieh
– sequence: 4
  givenname: Po-Jung
  surname: Chen
  fullname: Chen, Po-Jung
– sequence: 5
  givenname: Tsung-Kun
  orcidid: 0000-0001-9760-5070
  surname: Chang
  fullname: Chang, Tsung-Kun
– sequence: 6
  givenname: Yen-Cheng
  surname: Chen
  fullname: Chen, Yen-Cheng
– sequence: 7
  givenname: Ching-Chun
  surname: Li
  fullname: Li, Ching-Chun
– sequence: 8
  givenname: Yi-Chien
  surname: Hsieh
  fullname: Hsieh, Yi-Chien
– sequence: 9
  givenname: Hsiang-Lin
  surname: Tsai
  fullname: Tsai, Hsiang-Lin
– sequence: 10
  givenname: Jaw-Yuan
  orcidid: 0000-0002-7705-2621
  surname: Wang
  fullname: Wang, Jaw-Yuan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33064768$$D View this record in MEDLINE/PubMed
BookMark eNqNk9uK1TAUhouMOAd9A9GAIHqxt0mT9OCFMAweCgMDOnob0nS1O0Ob1CSdce58Bx_Dt_JJTN17ZO9hEOlFysq3_j_5yTpM9ow1kCSPCV4SmpNXF3ZyRvbLMZaXOGU4Z-m95ICUNF1kKaZ7W__7yaH3FxhzWmTZg2SfUpyxPCsOkp_negCkTQB3KXtUQ7gCMCisACk7jD0EbQ2yLXKy0TaWnRyvkTQNcra2QauF9F77AA3yk-vAxc3Bmg6NMmgwwaMrHVbIB9kBqn59_1FVFXKgQjRT0ihwaDINuM7qucmBHaNF0JfRfwWD3bZ9mNxvZe_h0WY9Sj6_e3t-8mFxeva-Ojk-XaisTMOiblLAPG0VxTkwVipeKNrSVjJS4JaUkJKsznkNDEiTFgxKzmSacR4BIJTQo-TpWnfsrRebnL1IGSecUhbzPEqqNdFYeSFGpwfproWVWvwpWNcJ6WI4PYi6yFKZs7ptqWKE5GWLGS8wxWleYK541HqzcZvqARoVQ3Oy3xHd3TF6JTp7KXKe5QzPx32xEXD26wQ-iEF7BX0vDdhpfe6C54TSiD67hd59uw3VyXgBbVobfdUsKo4zWvCS0qKI1PIOKn4NDFrFR9nqWN9peLnTEJkA30InJ-9F9enj_7NnX3bZ51vsCmQfVt720_xy_S74ZDvpvxHfTEMEXq8B5az3DlqhdJCzTrya7gXBYh69m9DEPHpiM3qxmd1qvtH_Z9tvoNM2eA
CitedBy_id crossref_primary_10_3390_cancers14174175
crossref_primary_10_3390_cancers15051358
crossref_primary_10_3389_fonc_2023_1099168
crossref_primary_10_3390_biomedicines9101371
crossref_primary_10_1111_ases_13055
crossref_primary_10_1371_journal_pone_0259460
crossref_primary_10_3390_jpm13050851
Cites_doi 10.1016/0140-6736(93)90207-W
10.1200/JCO.2005.02.1329
10.1097/SLA.0000000000003530
10.1002/bjs.1800691019
10.1097/SLA.0b013e3182196e1f
10.1245/s10434-012-2262-1
10.1016/S1470-2045(10)70172-8
10.1200/JCO.2006.06.7629
10.1200/JCO.1999.17.8.2396
10.1245/s10434-018-6738-5
10.1200/JCO.2002.07.132
10.1016/j.clcc.2017.10.012
10.1001/jama.2017.7219
10.1007/s00464-016-5289-8
10.1097/DCR.0000000000000266
10.1016/j.ctrv.2019.101908
10.1016/S0140-6736(05)66545-2
10.1200/JCO.2009.25.8376
10.1200/JCO.2016.67.6049
10.1002/kjm2.12161
10.18632/oncotarget.9995
10.1245/s10434-014-4278-1
10.1002/jso.20815
10.1016/j.ejso.2005.10.002
10.18632/oncotarget.16127
10.1245/s10434-019-07340-9
10.1002/bjs.9112
10.1007/s00464-016-5165-6
10.1200/JCO.2011.40.1836
10.1097/SLA.0000000000000368
10.1097/SLA.0b013e31817fc2a0
10.1002/bjs.5506
10.1007/s10350-004-6545-x
10.1016/S1470-2045(15)00159-X
10.1056/NEJMoa040694
10.1016/S1470-2045(12)70187-0
10.4251/wjgo.v10.i11.449
10.1177/1756283X16656690
10.1200/JCO.2005.02.113
10.1016/S1470-2045(15)00004-2
10.1186/s12885-020-6538-8
10.1186/s12893-017-0315-x
10.1007/s00268-008-9520-1
10.1007/s00464-010-1204-x
10.1200/JCO.2016.66.6198
10.1016/S1470-2045(13)70016-0
10.1200/JCO.2012.42.9597
ContentType Journal Article
Copyright COPYRIGHT 2020 Public Library of Science
2020 Huang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2020 Huang et al 2020 Huang et al
Copyright_xml – notice: COPYRIGHT 2020 Public Library of Science
– notice: 2020 Huang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2020 Huang et al 2020 Huang et al
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0240742
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni Edition)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Materials Science Collection
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
ProQuest Biological Science Collection
Agricultural Science Database
Health & Medical Collection (Alumni Edition)
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE



Agricultural Science Database



MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Medicine
DocumentTitleAlternate Time Interval between the completion of radiotherapy and robotic-assisted surgery
EISSN 1932-6203
ExternalDocumentID 2451533420
oai_doaj_org_article_b862a74bff3c41179f045803027805c5
PMC7567401
A638593388
33064768
10_1371_journal_pone_0240742
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Taiwan
GeographicLocations_xml – name: Taiwan
GrantInformation_xml – fundername: ;
  grantid: KMUH106-6M29, KMUH107-7R28, KMUH108-8R34, KMUH108-8R35, KMUH108-8M33, KMUH108-8M35, KMUH108-8M36, KMUHS10801, KMUHS10804, KMUHS10807, KMUH-DK109005~3
– fundername: ;
  grantid: KMU-TC108A04
– fundername: ;
  grantid: MOST108-2321-B-037-001, MOST107-2321-B-037-003, MOST107-2314-B-037-116, MOST107-2314-B-037-022-MY2, MOST107-2314-B-037-023-MY2
– fundername: ;
  grantid: MOHW107-TDU-B-212-123006, MOHW107-TDU-B-212-114026B, MOHW108-TDU-B-212-133006, MOHW108-TDU-B-212-124026
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
3V.
ADRAZ
BBORY
CGR
CUY
CVF
ECM
EIF
IPNFZ
NPM
RIG
PMFND
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
RC3
7X8
5PM
PUEGO
AAPBV
ABPTK
N95
ID FETCH-LOGICAL-c692t-bd2e052fc307e449c58c3f3fa4180f19e216b75be4e1d284e954a2655a41e1313
IEDL.DBID M48
ISSN 1932-6203
IngestDate Sun Jul 02 11:03:47 EDT 2023
Wed Aug 27 01:32:06 EDT 2025
Thu Aug 21 18:24:24 EDT 2025
Fri Jul 11 11:16:32 EDT 2025
Fri Jul 25 11:30:48 EDT 2025
Tue Jun 17 20:57:21 EDT 2025
Tue Jun 10 20:24:26 EDT 2025
Fri Jun 27 04:25:32 EDT 2025
Fri Jun 27 04:07:31 EDT 2025
Thu May 22 21:23:21 EDT 2025
Wed Feb 19 02:30:29 EST 2025
Thu Apr 24 22:58:35 EDT 2025
Tue Jul 01 04:11:29 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c692t-bd2e052fc307e449c58c3f3fa4180f19e216b75be4e1d284e954a2655a41e1313
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Competing Interests: The authors have declared that no competing interests exist.
ORCID 0000-0001-9760-5070
0000-0002-7705-2621
OpenAccessLink https://www.proquest.com/docview/2451533420?pq-origsite=%requestingapplication%
PMID 33064768
PQID 2451533420
PQPubID 1436336
PageCount e0240742
ParticipantIDs plos_journals_2451533420
doaj_primary_oai_doaj_org_article_b862a74bff3c41179f045803027805c5
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7567401
proquest_miscellaneous_2451857133
proquest_journals_2451533420
gale_infotracmisc_A638593388
gale_infotracacademiconefile_A638593388
gale_incontextgauss_ISR_A638593388
gale_incontextgauss_IOV_A638593388
gale_healthsolutions_A638593388
pubmed_primary_33064768
crossref_citationtrail_10_1371_journal_pone_0240742
crossref_primary_10_1371_journal_pone_0240742
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-10-16
PublicationDateYYYYMMDD 2020-10-16
PublicationDate_xml – month: 10
  year: 2020
  text: 2020-10-16
  day: 16
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2020
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References R Sauer (pone.0240742.ref004) 2012; 30
K Bujko (pone.0240742.ref019) 2006; 93
JH Lefèvre (pone.0240742.ref027) 2019; 270
AG Mace (pone.0240742.ref038) 2015; 58
DR Lim (pone.0240742.ref046) 2017; 31
J García-Aguilar (pone.0240742.ref011) 2003; 46
MY Huang (pone.0240742.ref024) 2020; 36
R Sauer (pone.0240742.ref005) 2004; 351
D Jayne (pone.0240742.ref048) 2017; 318
SB Lim (pone.0240742.ref028) 2008; 248
Y Francois (pone.0240742.ref022) 1999; 17
JK MacFarlane (pone.0240742.ref002) 1993; 341
J Garcia-Aguilar (pone.0240742.ref029) 2015; 16
JW Huh (pone.0240742.ref010) 2008; 32
JY Kim (pone.0240742.ref034) 2012; 19
D Du (pone.0240742.ref016) 2018; 17
C Rödel (pone.0240742.ref013) 2012; 13
CM Dolinsky (pone.0240742.ref017) 2007; 96
JP Gérard (pone.0240742.ref008) 2006; 24
MH van der Pas (pone.0240742.ref030) 2013; 14
P Rouanet (pone.0240742.ref047) 2018; 25
C Rödel (pone.0240742.ref014) 2015; 16
DW Kim (pone.0240742.ref009) 2006; 32
RJ Heald (pone.0240742.ref001) 1982; 69
F Petrelli (pone.0240742.ref025) 2016; 263
JF Bosset (pone.0240742.ref007) 2005; 23
Y Deng (pone.0240742.ref015) 2016; 34
CW Huang (pone.0240742.ref036) 2017; 17
DA Sloothaak (pone.0240742.ref041) 2013; 100
S Lichthardt (pone.0240742.ref042); 20
JE Tepper (pone.0240742.ref003) 2002; 20
I Abraha (pone.0240742.ref006) 2018; 10
M Hellan (pone.0240742.ref035) 2015; 22
J Garcia-Aguilar (pone.0240742.ref018) 2011; 254
CM Huang (pone.0240742.ref023) 2016; 9
YJ Yang (pone.0240742.ref039) 2016; 7
K Jones (pone.0240742.ref049) 2018; 10
M Maas (pone.0240742.ref012) 2010; 11
XL Fu (pone.0240742.ref040) 2017; 8
C Rödel (pone.0240742.ref050) 2005; 23
PJ Guillou (pone.0240742.ref031) 2005; 365
YT Chen (pone.0240742.ref033); 20
C Kane (pone.0240742.ref021) 2019; 81
SB Edge (pone.0240742.ref037) 2010
SY Ngan (pone.0240742.ref020) 2012; 30
JP Gérard (pone.0240742.ref044) 2010; 28
JH Lefevre (pone.0240742.ref026) 2016; 34
WL Law (pone.0240742.ref045) 2017; 31
JH Baek (pone.0240742.ref032) 2010; 25
CSD Roxburgh (pone.0240742.ref043) 2019; 26
References_xml – volume: 341
  start-page: 457
  year: 1993
  ident: pone.0240742.ref002
  article-title: Mesorectal excision for rectal cancer
  publication-title: Lancet
  doi: 10.1016/0140-6736(93)90207-W
– volume: 23
  start-page: 8688
  year: 2005
  ident: pone.0240742.ref050
  article-title: Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.02.1329
– volume: 270
  start-page: 747
  year: 2019
  ident: pone.0240742.ref027
  article-title: Does A Longer Waiting Period After Neoadjuvant Radio-chemotherapy Improve the Oncological Prognosis of Rectal Cancer?: Three Years' Follow-up Results of the Greccar-6 Randomized Multicenter Trial
  publication-title: Ann Surg
  doi: 10.1097/SLA.0000000000003530
– volume: 69
  start-page: 613
  year: 1982
  ident: pone.0240742.ref001
  article-title: The mesorectum in rectal cancer surgery—the clue to pelvic recurrence?
  publication-title: Br J Surg
  doi: 10.1002/bjs.1800691019
– volume: 254
  start-page: 97
  year: 2011
  ident: pone.0240742.ref018
  article-title: Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial
  publication-title: Ann Surg
  doi: 10.1097/SLA.0b013e3182196e1f
– volume: 19
  start-page: 2485
  year: 2012
  ident: pone.0240742.ref034
  article-title: A comparative study of voiding and sexual function after total mesorectal excision with autonomic nerve preservation for rectal cancer: laparoscopic versus robotic surgery
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-012-2262-1
– volume: 11
  start-page: 835
  year: 2010
  ident: pone.0240742.ref012
  article-title: Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(10)70172-8
– volume: 24
  start-page: 4620
  year: 2006
  ident: pone.0240742.ref008
  article-title: Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2006.06.7629
– volume: 17
  start-page: 2396
  year: 1999
  ident: pone.0240742.ref022
  article-title: Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.1999.17.8.2396
– volume: 25
  start-page: 3572
  year: 2018
  ident: pone.0240742.ref047
  article-title: Robotic Versus Laparoscopic Total Mesorectal Excision for Sphincter-Saving Surgery: Results of a Single-Center Series of 400 Consecutive Patients and Perspectives
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-018-6738-5
– volume: 20
  start-page: 1744
  year: 2002
  ident: pone.0240742.ref003
  article-title: Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control—final report of intergroup 0114
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2002.07.132
– volume: 17
  start-page: 13
  year: 2018
  ident: pone.0240742.ref016
  article-title: Optimal Interval to Surgery After Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Systematic Review and Meta-analysis
  publication-title: Clin Colorectal Cancer
  doi: 10.1016/j.clcc.2017.10.012
– volume: 318
  start-page: 1569
  year: 2017
  ident: pone.0240742.ref048
  article-title: Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer: The ROLARR Randomized Clinical Trial
  publication-title: JAMA
  doi: 10.1001/jama.2017.7219
– volume: 31
  start-page: 2798
  year: 2017
  ident: pone.0240742.ref045
  article-title: Comparison of short-term and oncologic outcomes of robotic and laparoscopic resection for mid- and distal rectal cancer
  publication-title: Surg Endosc
  doi: 10.1007/s00464-016-5289-8
– volume: 58
  start-page: 32
  year: 2015
  ident: pone.0240742.ref038
  article-title: American Joint Committee on Cancer and College of American Pathologists regression grade: a new prognostic factor in rectal cancer
  publication-title: Dis Colon Rectum
  doi: 10.1097/DCR.0000000000000266
– volume: 81
  start-page: 101908
  year: 2019
  ident: pone.0240742.ref021
  article-title: Should we favour the use of 5 × 5 preoperative radiation in rectal cancer
  publication-title: Cancer Treat Rev
  doi: 10.1016/j.ctrv.2019.101908
– volume: 365
  start-page: 1718
  year: 2005
  ident: pone.0240742.ref031
  article-title: Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)66545-2
– volume: 28
  start-page: 1638
  year: 2010
  ident: pone.0240742.ref044
  article-title: Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2009.25.8376
– volume: 10
  start-page: CD002102
  year: 2018
  ident: pone.0240742.ref006
  article-title: Preoperative radiotherapy and curative surgery for the management of localised rectal carcinoma
  publication-title: Cochrane Database Syst Rev
– volume: 34
  start-page: 3773
  year: 2016
  ident: pone.0240742.ref026
  article-title: Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6)
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2016.67.6049
– volume: 36
  start-page: 152
  issue: 3
  year: 2020
  ident: pone.0240742.ref024
  article-title: Surgical treatment following neoadjuvant chemoradiotherapy in locally advanced rectal cancer
  publication-title: Kaohsiung J Med Sci
  doi: 10.1002/kjm2.12161
– volume: 7
  start-page: 45513
  year: 2016
  ident: pone.0240742.ref039
  article-title: Fluorouracil-based neoadjuvant chemoradiotherapy with or without oxaliplatin for treatment of locally advanced rectal cancer: An updated systematic review and meta-analysis
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.9995
– volume: 22
  start-page: 2151
  year: 2015
  ident: pone.0240742.ref035
  article-title: Robotic Rectal Cancer Resection: A Retrospective Multicenter Analysis
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-014-4278-1
– volume: 96
  start-page: 207
  year: 2007
  ident: pone.0240742.ref017
  article-title: Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil or 5-fluorouracil and oxaliplatin on outcomes in rectal cancer
  publication-title: J Surg Oncol
  doi: 10.1002/jso.20815
– volume: 32
  start-page: 162
  year: 2006
  ident: pone.0240742.ref009
  article-title: Pre-operative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3 cm of the anal verge
  publication-title: Eur J Surg Oncol
  doi: 10.1016/j.ejso.2005.10.002
– volume: 8
  start-page: 34340
  year: 2017
  ident: pone.0240742.ref040
  article-title: Meta-analysis of oxaliplatin-based versus fluorouracil-based neoadjuvant chemoradiotherapy and adjuvant chemotherapy for locally advanced rectal cancer
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.16127
– volume: 26
  start-page: 2019
  year: 2019
  ident: pone.0240742.ref043
  article-title: Role of the Interval from Completion of Neoadjuvant Therapy to Surgery in Postoperative Morbidity in Patients with Locally Advanced Rectal Cancer
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-019-07340-9
– volume: 100
  start-page: 933
  year: 2013
  ident: pone.0240742.ref041
  article-title: Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer
  publication-title: Br J Surg
  doi: 10.1002/bjs.9112
– start-page: 143
  year: 2010
  ident: pone.0240742.ref037
– volume: 31
  start-page: 1728
  year: 2017
  ident: pone.0240742.ref046
  article-title: Long-term oncological outcomes of robotic versus laparoscopic total mesorectal excision of mid-low rectal cancer following neoadjuvant chemoradiation therapy
  publication-title: Surg Endosc
  doi: 10.1007/s00464-016-5165-6
– volume: 30
  start-page: 1926
  year: 2012
  ident: pone.0240742.ref004
  article-title: Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2011.40.1836
– volume: 263
  start-page: 458
  year: 2016
  ident: pone.0240742.ref025
  article-title: Increasing the Interval Between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer: A Meta-analysis of Published Studies
  publication-title: Ann Surg
  doi: 10.1097/SLA.0000000000000368
– volume: 248
  start-page: 243
  year: 2008
  ident: pone.0240742.ref028
  article-title: Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers
  publication-title: Ann Surg
  doi: 10.1097/SLA.0b013e31817fc2a0
– volume: 93
  start-page: 1215
  year: 2006
  ident: pone.0240742.ref019
  article-title: Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer
  publication-title: Br J Surg
  doi: 10.1002/bjs.5506
– volume: 46
  start-page: 298
  year: 2003
  ident: pone.0240742.ref011
  article-title: A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision.
  publication-title: Dis Colon Rectum
  doi: 10.1007/s10350-004-6545-x
– volume: 16
  start-page: 979
  year: 2015
  ident: pone.0240742.ref014
  article-title: Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(15)00159-X
– volume: 351
  start-page: 1731
  year: 2004
  ident: pone.0240742.ref005
  article-title: Preoperative versus postoperative chemoradiotherapy for rectal cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa040694
– volume: 13
  start-page: 679
  year: 2012
  ident: pone.0240742.ref013
  article-title: Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(12)70187-0
– volume: 10
  start-page: 449
  year: 2018
  ident: pone.0240742.ref049
  article-title: Robotic total meso-rectal excision for rectal cancer: A systematic review following the publication of the ROLARR trial
  publication-title: World J Gastrointest Oncol
  doi: 10.4251/wjgo.v10.i11.449
– volume: 9
  start-page: 702
  year: 2016
  ident: pone.0240742.ref023
  article-title: An observational study of extending FOLFOX chemotherapy, lengthening the interval between radiotherapy and surgery, and enhancing pathological complete response rates in rectal cancer patients following preoperative chemoradiotherapy.
  publication-title: Therap Adv Gastroenterol
  doi: 10.1177/1756283X16656690
– volume: 20
  start-page: 23
  ident: pone.0240742.ref033
  article-title: An observational study of patho-oncological outcomes of various surgical methods in total mesorectal excision for rectal cancer: a single center analysis
  publication-title: BMC Surg 2020
– volume: 23
  start-page: 5620
  year: 2005
  ident: pone.0240742.ref007
  article-title: Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results—EORTC 22921
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.02.113
– volume: 16
  start-page: 957
  year: 2015
  ident: pone.0240742.ref029
  article-title: Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(15)00004-2
– volume: 20
  start-page: 49
  ident: pone.0240742.ref042
  article-title: Pathological complete response due to a prolonged time interval between preoperative chemoradiation and surgery in locally advanced rectal cancer: analysis from the German StuDoQ|Rectalcarcinoma registry
  publication-title: BMC Cancer
  doi: 10.1186/s12885-020-6538-8
– volume: 17
  start-page: 126
  year: 2017
  ident: pone.0240742.ref036
  article-title: Robotic-assisted total mesorectal excision with the single-docking technique for patients with rectal cancer
  publication-title: BMC Surg
  doi: 10.1186/s12893-017-0315-x
– volume: 32
  start-page: 1116
  year: 2008
  ident: pone.0240742.ref010
  article-title: Sphincter-preserving operations following preoperative chemoradiation: an alternative to abdominoperineal resection for lower rectal cancer?
  publication-title: World J Surg
  doi: 10.1007/s00268-008-9520-1
– volume: 25
  start-page: 521
  year: 2010
  ident: pone.0240742.ref032
  article-title: Robotic and laparoscopic total mesorectal excision for rectal cancer: a case-matched study
  publication-title: Surg Endosc
  doi: 10.1007/s00464-010-1204-x
– volume: 34
  start-page: 3300
  year: 2016
  ident: pone.0240742.ref015
  article-title: Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2016.66.6198
– volume: 14
  start-page: 210
  year: 2013
  ident: pone.0240742.ref030
  article-title: Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial.
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(13)70016-0
– volume: 30
  start-page: 3827
  year: 2012
  ident: pone.0240742.ref020
  article-title: Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2012.42.9597
SSID ssj0053866
Score 2.3792639
Snippet This aim of this study was to evaluate the effects of time interval between the completion of radiotherapy and robotic-assisted surgery on the outcomes among...
Background This aim of this study was to evaluate the effects of time interval between the completion of radiotherapy and robotic-assisted surgery on the...
BackgroundThis aim of this study was to evaluate the effects of time interval between the completion of radiotherapy and robotic-assisted surgery on the...
Background This aim of this study was to evaluate the effects of time interval between the completion of radiotherapy and robotic-assisted surgery on the...
SourceID plos
doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e0240742
SubjectTerms Adult
Aged
Aged, 80 and over
Cancer
Care and treatment
Chemoradiotherapy
Chemotherapy
Clinical outcomes
Clinical trials
Colorectal cancer
Colorectal surgery
Female
Hospitals
Humans
Kaplan-Meier Estimate
Laparoscopy
Magnetic resonance imaging
Male
Medical schools
Medicine
Medicine and Health Sciences
Metastases
Methods
Middle Aged
Neoplasm Staging
Patient outcomes
Patients
Postoperative Complications - etiology
Preoperative Care
Radiation therapy
Radiotherapy
Rectal Neoplasms - pathology
Rectal Neoplasms - surgery
Rectal Neoplasms - therapy
Rectum
Robotic surgery
Robotic Surgical Procedures
Sphincter
Surgery
Survival
Time Factors
Treatment Outcome
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQnrggyquBAgYhAYe0iWPncSyIquEAElDUm5U49rJSiVfJ7oGfxL9kxvZGG1SpHLiux8lmZjyesWe-IeSV5qKoOo0Y-0zEXKkyLjsIVsAXAQUxHR7uY7bFp_z8gn-8FJd7rb4wJ8zDA3vGnbTgcjcFb43JFEf8MoNXewlet5WJUA69FPa8XTDlbTCs4jwPhXJZkZ4EuRyvba-PEdWr4Gy2ETm8_skqL9ZXdrzO5fw7c3JvKzq7S-4EH5Ke-v9-QG7p_h45CKt0pG8ClPTb--Q3VnjQlctrhBkhKYuC00ddLrlGsVBr6NB0q1CL9Ys2fUcH21p4fAy-NSpCR0dfP01ddyIa4FhHiue4FDzMpaZ1XNc1RQsKr1KoTQPFErVhaVc4ZdB2rT3QOAVV-Wn3X_qAXJx9-Pb-PA7NGWKVV2wTtx3TiWBGgZHQnFdKlCozmWl4WiYmrTRL87YQreY67WAP1JXgDcuFAAKdZmn2kCx6EMchoaXiTQWuRqFSxfFWSKiqa_IyTzRrFSsjku0kJVVALscGGlfSXccVEMF4xkuUrwzyjUg8zVp75I4b6N-hEky0iLvtfgBtlEEb5U3aGJHnqELSF7FO1kOegpkTVZaV8DEvHQVib_SY3LNstuMo68_f_4Ho65cZ0etAZCywQzWhoAK-CTG9ZpRHM0qwIGo2fIgKv-PKKBkXGAZwlsDM3SK4fvjFNIwPxYS9XtutpykFnoBE5JFfMxNnM4x6IcyNSDFbTTPWz0f61Q8HfV6IHFtIPv4fsnpCbjM8PMH0pPyILDbDVj8FD3PTPnPG5A8I4nrE
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NbtQwELZgkRAXRMtPQwsYhAQc0iaOHScnVBBVgwRIQNHeosR2lpVKnCa7B268A4_BW_EkzCTe0KAKuK7H8cbzk7Fn5htCHhsuZKoNYuwz4XOlEj_RcFgBXwQEpNJ4uY_ZFm_j4xP-ei7m7sKtc2mVG5vYG2ptFd6RHzAu0DXhLHjenPnYNQqjq66FxmVyBaHLMKVLzscDF-hyHLtyuUiGB447-42tzT5ie0nOJp-jHrV_tM2z5tR2Fzmef-ZPnvsgHd0g150nSQ8H1m-RS6beJlffuFj5NtlyatvRpw5b-tlN8gNLPuiyT3SEyS5Li4IXSPvkcoN8oraibaGXrjjrKy1qTVtbWljJB2cbJUPTbiiopn27IurwWTuKF7sUXM6FodnPb9-zLKNoVGExhQLWUqxaaxd2iZNaYxszYI9TkJ4v9vyyt8jJ0auPL49916_BV3HKVn6pmQkEqxTYDcN5qkSioiqqCh4mQRWmhoVxKUVpuAk1fBZNKnjBYiGAwIRRGN0msxp4s0NooniRgvchVag4BoqESnURJ3FgWKlY4pFow7ZcOTBz7KlxmvcROgmHmoELOTI7d8z2iD_OagYwj3_Qv0CJGGkRirv_wbaL3Gl2XsKZsJC8rKpIcQTYqzD2HGA8OAmEEh55gPKUD3Wto0HJD8HyiTSKEniZRz0FwnHUmO-zKNZdl2fvPv0H0Yf3E6InjqiysB2qcDUW8E4I8zWh3JtQglFRk-EdlP7NrnT5b_WDmRuNuHj44TiMD8UcvtrY9UCTCLwU8cidQYHGnY3wIAwnX4_IiWpNtn46Ui8_92joUsTYVfLu3__WLrnG8KYEc5HiPTJbtWtzD9zJVXm_txm_ABYPeJw
  priority: 102
  providerName: ProQuest
Title Time interval between the completion of radiotherapy and robotic-assisted surgery among patients with stage I–III rectal cancer undergoing preoperative chemoradiotherapy
URI https://www.ncbi.nlm.nih.gov/pubmed/33064768
https://www.proquest.com/docview/2451533420
https://www.proquest.com/docview/2451857133
https://pubmed.ncbi.nlm.nih.gov/PMC7567401
https://doaj.org/article/b862a74bff3c41179f045803027805c5
http://dx.doi.org/10.1371/journal.pone.0240742
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELe27oUXxPhaYRSDkICHVIljx8kDQtvUsiIx0KCob1HiOKVSSUrSSuyF_4f_kjvHjRZUPl7yUJ9T5Xx3vrPvfkfIM82FjDKNGPtMOFyp0AkzCFbAFwEByTM83Mdsi4vgfMrfzsRsj2x7tloG1jtDO-wnNa2Ww-_frl6Dwr8yXRukt500XJWFHiJmF4R7--QA9iaJqvqOt_cKoN3m9hK9Fidgrm-L6f70ls5mZTD9W8vdWy3Lepdb-nt25bXtanyL3LR-Jj1pBOOQ7OniNjm0mlzTFxZu-uUd8hOrQOjC5D7CDJu4RcExpCbfXOPS0TKnVZItbL3WFU2KjFZlWsLrHfC_UVgyWjc11tR0MKIWsrWmeNZLwQudazpxJpMJRSsLf6VQ4iqKZWzVvFzglEoD-xswcgri9LW8_qd3yXQ8-nR27tgGDo4KIrZ20oxpV7BcgSHRnEdKhMrP_TzhXujmXqSZF6RSpJprL4N9UkeCJywQAgi053v-PdIrYDmOCA0VTyJwR6TyFMebI6GiLAnCwNUsVSzsE3-7UrGy6ObYZGMZmys7CVFOw_gY1ze269snTjtr1aB7_IP-FIWgpUVsbvNDWc1jq-pxCkFiInma577iiLiX42W0ixfEoSuU6JPHKEJxU-jaWpj4BEyhiHw_hI95aigQn6PABKB5sqnrePL-838QfbzsED23RHkJ7FCJLbqAb0Lcrw7lcYcSrIzqDB-hwG-5UseMCwwVOHNh5lYJdg8_aYfxpZjUV-hy09CEAk9J-uR-ozMtZ32MjCEU7hPZ0aYO67sjxeKLgUeXIsA2kw_-_kEPyQ2GRyeYnBQck9662uhH4F-u0wHZlzMJz_DMw-f4zYAcnI4uPlwOzInNwJgUfP4Y_QLNAoFz
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKIgEXRMujC4UaBIIe0iaOnccBofKoNvSBBC3aW0gcZ1mpxEuyK9Qb_4GfgcSP4pcwkzihQRVw6XU9Tjae8ecZz4uQh4oLP8wU1thnwuJSBlaQgbECuggISJ7h5T5GWxx4oyP-eizGS-RHmwuDYZUtJtZAnWmJd-RbjAtUTTizn80-W9g1Cr2rbQuNRix21ckXMNmqp9FL4O8jxnZeHb4YWaargCW9kM2tNGPKFiyXIN2K81CKQLq5myfcCezcCRVzvNQXqeLKyQC8VSh4wjwhgEA5ruPCcy-Qi3Dw2rij_HFn4AF2eJ5Jz3N9Z8tIw-ZMF2oTa4n5nPWOv7pLQHcWDGbHujpL0f0zXvPUAbhzjVw1mivdbkRtmSypYoVc2je--RWybGCiok9MLeuN6-Q7ppjQaR1YCZNNVBgFrZPWwewK5YLqnJZJNjXJYCc0KTJa6lTDmyxQ7lESM1o1Cdy0bo9ETT3YiuJFMgUVd6Jo9PPrtyiKKII4vEyiQJcUs-TKiZ7ipFLpmWpqnVOQ1k_69GtvkKNz4eRNMiiAN6uEBpInIWg7vnQkR8eUkGGWeIFnK5ZKFgyJ27ItlqZ4OvbwOI5rj6APRlTDhRiZHRtmD4nVzZo1xUP-Qf8cJaKjxdLf9Q-6nMQGSeIUbNDE52meu5JjQb8cfd02-p8DW0gxJOsoT3GTR9sBWLwNSCtC1w3gYx7UFFj-o8D4okmyqKo4evP-P4jeve0RPTZEuYblkInJ6YBvwrJiPcq1HiWAmOwNr6L0t6tSxb-3O8xsd8TZw_e7YXwoxgwWSi8amkDgJcyQ3Go2ULeyLhreYGkPid_bWr2l748U04919XVfeNjF8vbf_9Y6uTw63N-L96KD3TvkCsNbGoyD8tbIYF4u1F1QZefpvRo_KPlw3oD1C_4WtG0
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELbKIlVcEC0_XSjUIBBwSDdx7PwcECqUVUOhIKBobyFxnGWlEi_JrlBvvAOPwRvwODwJM4kTGlQBl17X43jjGX-Z8fwRcldx4YeZwhr7TFhcysAKMjBWQBcBAckzvNzHaIsDb--QP5-IyQr50ebCYFhli4k1UGda4h35iHGBqgln9ig3YRGvd8eP558t7CCFnta2nUYjIvvq-AuYb9WjaBd4fY-x8bN3T_cs02HAkl7IFlaaMWULlkuQdMV5KEUg3dzNE-4Edu6Eijle6otUceVkAOQqFDxhnhBAoBzXceG558h53xUOnjF_0hl7gCOeZ1L1XN8ZGcnYnutCbWNdMZ-z3qew7hjQfRcG8yNdnab0_hm7eeJjOL5ELhotlu40YrdGVlSxTlZfGj_9OlkzkFHRB6au9cPL5Dumm9BZHWQJk02EGAUNlNaB7QplhOqclkk2M4lhxzQpMlrqVMNKFij6KJUZrZpkblq3SqKmNmxF8VKZgro7VTT6-fVbFEUUAR0WkyjcJcWMuXKqZzipVHqumrrnFCT3kz657BVyeCacvEoGBfBmg9BA8iQEzceXjuTopBIyzBIv8GzFUsmCIXFbtsXSFFLHfh5Hce0d9MGgargQI7Njw-whsbpZ86aQyD_on6BEdLRYBrz-QZfT2KBKnII9mvg8zXNXcizul6Pf20ZfdGALKYZkC-UpbnJqOzCLdwB1Rei6AbzMnZoCS4EUeKimybKq4ujV-_8gevumR3TfEOUatkMmJr8D3glLjPUoN3uUAGiyN7yB0t_uShX_Pvowsz0Rpw_f7obxoRg_WCi9bGgCgRcyQ3KtOUDdzrpohIPVPSR-72j1tr4_Usw-1pXYfeFhR8vrf_9bW2QVoCp-ER3s3yAXGF7YYEiUt0kGi3KpboJWu0hv1fBByYezxqtfYci4ow
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Time+interval+between+the+completion+of+radiotherapy+and+robotic-assisted+surgery+among+patients+with+stage+I-III+rectal+cancer+undergoing+preoperative+chemoradiotherapy&rft.jtitle=PloS+one&rft.au=Huang%2C+Ching-Wen&rft.au=Su%2C+Wei-Chih&rft.au=Yin%2C+Tzu-Chieh&rft.au=Chen%2C+Po-Jung&rft.date=2020-10-16&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=15&rft.issue=10&rft.spage=e0240742&rft_id=info:doi/10.1371%2Fjournal.pone.0240742&rft.externalDocID=A638593388
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon